Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

Teknova announces new CEO

By Sean Whooley | July 24, 2020

Cell culture media, protein purification and molecular biology reagent manufacturer Teknova announced that it appointed Stephen Gunstream as its new CEO.

Gunstream has nearly 20 years of experience in life sciences, having previously served as VP and GM for the research and clinical business at BD Biosciences, as well as the CCO at Integrated DNA Technologies. He will take over for founder and retiring CEO Ted Davis, who said in a news release that the Gunstream “understands our culture and vision extremely well.”

“Teknova is a special company,” Gunstream said. “First and foremost, it is due to the people in the organization, and I feel very privileged to lead them as CEO. Ted has built a wonderful business that is always asking what we can do to advance scientific breakthroughs and then delivering. It is a great fit as my fundamental belief is that a business will be successful, no matter what, if you focus on the customer.”

Hollister, Calif.-based Teknova is an ISO 13485-certified manufacturer of cell culture media and supplements, protein purification buffers, and molecular biology reagents.

About The Author

Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at swhooley@wtwhmedia.com.

Tell Us What You Think! Cancel reply

Related Articles Read More >

AstraZeneca
AstraZeneca to invest $2B in Maryland, support 2,600 jobs
This is the logo of Novartis.
Novartis opens new manufacturing plant in California
Coriolis meter options for pharmaceutical applications
samsung biologics (1)
Samsung Biologics completes Bioepis spinoff to become pure-play pharma CDMO
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE